TAMs upregulate the indoleamine 2,3‐dioxygenase (IDO) and the rate limiting enzyme of Trp and inhibit the tumor immune response, thus promoting the malignant progression of tumors.87 This evidence concerns the gene IDO1 and neoplasm.